Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Cantor Fitzgerald
Fuji
Chinese Patent Office
Cipla
US Army
Harvard Business School
Accenture
Medtronic

Generated: June 22, 2018

DrugPatentWatch Database Preview

Details for Patent: RE39181

« Back to Dashboard

Summary for Patent: RE39181
Title:Aqueous risperidone formulations
Abstract:The present invention is concerned with physicochemically stable aqueous solutions of risperidone for oral and parenteral administration; processes for preparing such formulations.
Inventor(s): Francois; Marc Karel Jozef (Beerse, BE), Dries; Willy Maria Albert Carlo (Beerse, BE)
Assignee:
Application Number:09/955,274
Patent Claim Types:
see list of patent claims
Formulation; Compound; Dosage form; Process;

Drugs Protected by US Patent RE39181

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Family Members for US Patent RE39181

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Croatia P950397 ➤ Try a Free Trial
Hong Kong 1010691 ➤ Try a Free Trial
Cyprus 2268 ➤ Try a Free Trial
Germany 69523313 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
QuintilesIMS
AstraZeneca
McKinsey
Fish and Richardson
Citi
UBS
Boehringer Ingelheim
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.